Literature DB >> 17449195

Physiologic and radiographic evidence of the distal edge of the proton beam in craniospinal irradiation.

Stephanie C Krejcarek1, P Ellen Grant, John W Henson, Nancy J Tarbell, Torunn I Yock.   

Abstract

PURPOSE: Fatty replacement of bone marrow resulting from radiation therapy can be seen on T1-weighted magnetic resonance (MR) images. We evaluated the radiographic appearance of the vertebral bodies in children treated with proton craniospinal irradiation (CSI) to illustrate the distal edge effect of proton radiotherapy. METHODS AND MATERIALS: The study cohort consisted of 13 adolescents aged 12-18 years who received CSI with proton radiotherapy at Massachusetts General Hospital. Ten of these patients had reached maximal or near-maximal growth. Proton beam radiation for these 10 patients was delivered to the thecal sac and exiting nerve roots only, whereas the remaining 3 patients had a target volume that included the thecal sac, exiting nerve roots, and entire vertebral bodies. Median CSI dose was 27 [range, 23.4-36] cobalt gray equivalent (CGE) given in 1.8-CGE fractions. Magnetic resonance images of the spine were obtained after completion of radiotherapy.
RESULTS: Magnetic resonance images of patients who received proton radiotherapy to the thecal sac only demonstrate a sharp demarcation of hyperintense T1-weighted signal in the posterior aspects of the vertebral bodies, consistent with radiation-associated fatty marrow replacement. Magnetic resonance images of the patients prescribed proton radiotherapy to the entire vertebral column had corresponding hyperintense T1-weighted signal involving the entire vertebral bodies.
CONCLUSION: The sharp delineation of radiation-associated fatty marrow replacement in the vertebral bodies demonstrates the rapid decrease in energy at the edge of the proton beam. This provides evidence for a sharp fall-off in radiation dose and supports the premise that proton radiotherapy spares normal tissues unnecessary irradiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17449195      PMCID: PMC1955224          DOI: 10.1016/j.ijrobp.2007.02.021

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

Review 1.  New technologies in radiation therapy for pediatric brain tumors: the rationale for proton radiation therapy.

Authors:  David G Kirsch; Nancy J Tarbell
Journal:  Pediatr Blood Cancer       Date:  2004-05       Impact factor: 3.167

2.  Effect of radiation therapy on thoracic and lumbar bone marrow: evaluation with MR imaging.

Authors:  D F Yankelevitz; C I Henschke; P H Knapp; L Nisce; Y Yi; P Cahill
Journal:  AJR Am J Roentgenol       Date:  1991-07       Impact factor: 3.959

3.  Radiation scoliosis; an experimental study.

Authors:  A M ARKIN; N SIMON
Journal:  J Bone Joint Surg Am       Date:  1950-04       Impact factor: 5.284

4.  Acute toxicity and treatment interruption related to electron and photon craniospinal irradiation in pediatric patients treated at the University of Texas M. D. Anderson Cancer Center.

Authors:  Eric L Chang; Pamela Allen; Catherine Wu; Joann Ater; John Kuttesch; Moshe H Maor
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-03-15       Impact factor: 7.038

Review 5.  Technology insight: Proton beam radiotherapy for treatment in pediatric brain tumors.

Authors:  Torunn I Yock; Nancy J Tarbell
Journal:  Nat Clin Pract Oncol       Date:  2004-12

6.  Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.

Authors:  V Oyharcabal-Bourden; C Kalifa; J C Gentet; D Frappaz; C Edan; P Chastagner; E Sariban; A Pagnier; A Babin; F Pichon; S Neuenschwander; M Vinchon; D Bours; V Mosseri; C Le Gales; M Ruchoux; C Carrie; F Doz
Journal:  J Clin Oncol       Date:  2005-07-20       Impact factor: 44.544

7.  Hypothalamic-pituitary dysfunction after radiation for brain tumors.

Authors:  L S Constine; P D Woolf; D Cann; G Mick; K McCormick; R F Raubertas; P Rubin
Journal:  N Engl J Med       Date:  1993-01-14       Impact factor: 91.245

8.  Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma.

Authors:  W H St Clair; J A Adams; M Bues; B C Fullerton; Sean La Shell; H M Kooy; J S Loeffler; N J Tarbell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

9.  Hematopoietic marrow regeneration in pediatric patients undergoing spinal irradiation: MR depiction.

Authors:  E C Cavenagh; E Weinberger; D W Shaw; K S White; J R Geyer
Journal:  AJNR Am J Neuroradiol       Date:  1995-03       Impact factor: 3.825

10.  Medulloblastoma: staging and treatment outcome.

Authors:  M Deutsch
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-06       Impact factor: 7.038

View more
  12 in total

1.  Early Axial Growth Outcomes of Pediatric Patients Receiving Proton Craniospinal Irradiation.

Authors:  Brian De; Oren Cahlon; Kevin Sine; Dennis Mah; Eugen B Hug; Suzanne L Wolden
Journal:  J Pediatr Hematol Oncol       Date:  2018-11       Impact factor: 1.289

Review 2.  Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials.

Authors:  Nitin Ohri; Xinglei Shen; Adam P Dicker; Laura A Doyle; Amy S Harrison; Timothy N Showalter
Journal:  J Natl Cancer Inst       Date:  2013-03-06       Impact factor: 13.506

Review 3.  The physical basis and future of radiation therapy.

Authors:  T Bortfeld; R Jeraj
Journal:  Br J Radiol       Date:  2011-06       Impact factor: 3.039

4.  Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.

Authors:  Christian L Barney; Aaron P Brown; David R Grosshans; Mary Frances McAleer; John F de Groot; Vinay Puduvalli; Susan L Tucker; Cody N Crawford; Mark R Gilbert; Paul D Brown; Anita Mahajan
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

Review 5.  The physics of proton therapy.

Authors:  Wayne D Newhauser; Rui Zhang
Journal:  Phys Med Biol       Date:  2015-03-24       Impact factor: 3.609

6.  Cost implications of the rapid adoption of newer technologies for treating prostate cancer.

Authors:  Paul L Nguyen; Xiangmei Gu; Stuart R Lipsitz; Toni K Choueiri; Wesley W Choi; Yin Lei; Karen E Hoffman; Jim C Hu
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

7.  Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.

Authors:  Phillip J Taddei; Dragan Mirkovic; Jonas D Fontenot; Annelise Giebeler; Yuanshui Zheng; David Kornguth; Radhe Mohan; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2009-03-20       Impact factor: 3.609

8.  Proton Therapy: Ever Shifting Sands and the Opportunities and Obligations within.

Authors:  Christine E Hill-Kayser; Stefan Both; Zelig Tochner
Journal:  Front Oncol       Date:  2011-09-06       Impact factor: 6.244

9.  Proton radiotherapy for solid tumors of childhood.

Authors:  Shane E Cotter; Sean M McBride; Torunn I Yock
Journal:  Technol Cancer Res Treat       Date:  2012-03-15

10.  Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data.

Authors:  Stephanie E Combs; Kerstin A Kessel; Klaus Herfarth; Alexandra Jensen; Susanne Oertel; Claudia Blattmann; Swantje Ecker; Angelika Hoess; Eike Martin; Olaf Witt; Oliver Jäkel; Andreas E Kulozik; Jürgen Debus
Journal:  Radiat Oncol       Date:  2012-10-17       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.